chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Return occurrence of Parsonage-Turner Syndrom affecting left arm/back/neck-hand and first two digits.; Return occurrence of Parsonage-Turner Syndrom affecting left arm/back/neck-hand and first two digits.; Swollen and painful left lymph node; Swollen and painful left lymph node; receiving 3rd dose of vaccine; receiving 3rd dose of vaccine; This is a spontaneous report from a contactable other HCP. A 53-year-old male patient received third dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: FD8448), via an unspecified route of administration, administered in Arm Right on 25Aug2021 10:45 as DOSE 3, SINGLE (at the age of: 53-year-old) for covid-19 immunization. Medical history included coronary artery disease other medical history: Mild CAD, Migraine, Psoriasis , migraine other medical history: Mild CAD, Migraine, Psoriasis , psoriasis other medical history: Mild CAD, Migraine, Psoriasis , Sulfonamide allergy as known allergies: Sulpha. Facility where the most recent COVID-19 vaccine was administered as Pharmacy or Drug Store. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and the patient received other medications within 2 weeks of vaccination as Finasteride, Atorvastatin, Acitretin. Concomitant medication(s) included finasteride (FINASTERIDE); atorvastatin (ATORVASTATIN); acitretin (ACITRETIN). Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient has been tested for COVID-19. On 08Sep2021, the patient experienced return occurrence of parsonage-turner syndrom affecting left arm/back/neck-hand and first two digits. On 08Sep2021 the patient experienced swollen and painful left lymph node. On 25Aug2021 10:45 the patient experienced receiving 3rd dose of vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 31Aug2021. Therapeutic measures were taken as Steroids, gabapentin as a result of return occurrence of parsonage-turner syndrom affecting left arm/back/neck-hand and first two digits, swollen and painful left lymph node. The outcome of event receiving 3rd dose of vaccine was unknown. The outcome of rest all event was not recovered.  Follow-up (22Sep2021): Follow-up attempts are completed. No further information is expected.
pt hospitalized w/bronchiolitis (RSV) & failure to thrive w/early dehydration @ 12 days old;sx leading up to this include fatigue, cough, congestion, vomiting, erythematous rash, ear infect, & rales in chest;
Initial unsolicited report received from a non health care professional on 18 Nov 2016. This case was linked with case 2016SA214043. This case involves a patient (gender and age not reported) who was vaccinated with a dose of FLUZONE QIV MDV (Batch number: UI678AB, expiry date: 30-Jun-2017, dose, dose in series and site of administration were not reported) intramuscularly on an unspecified date. Patient's medical history as Pre-existing physician diagnosed allergies, birth defects, medical conditions (specify) was not reported. Illness at the time of vaccination was reported as none. Concomitant medications were not reported. Any other vaccinations within four weeks of vaccinations were reported as none. On an unknown date, following the vaccination, the patient had developed some arm swelling with pain and a low grade fever of 100.8 F. The patient visited an urgent care (emergency room or ER) on 10 Nov (year unspecified) three days after receiving the vaccine. Other laboratory investigations were reported as none. The patient was treated with ice as corrective treatment. The patient was recovered from all the events on an unknown date. List of documents held by sender: none.
6/26/09 AT 0930AM DAD CALLED REPORTED CHILD RECEIVED IMM ON 6/23/09.  PATIENT HAD COUGH, RUNNY NOSE AND LOSS OF APPETITE THAT STARTED ON 6/24/09.  NURSE INSTRUCTED TO TAKE BABY TO HOSPITAL FOR MD EVALUATION.  DR WHO IS COVERING FOR ORIGINAL DR NOTIFIED.
Rash appeared in 2-3? diameter around injection site approximately 1 week after the injection. Applied lotion and took benadryl for 2 days and symptoms went away
This spontaneous report as received from Pfizer Inc via a pharmacist refers to a 60 year old patient of unknown gender. It was reported a patient took PNEUMOVAX 23 a year ago. The patient was supposed to receive PREVNAR 13 a year later but instead the patient received a second PNEUMOVAX 23 injection. It was reported a physician (relationship to patient unspecified) was aware that this has occurred. "The caller wanted to know what is the interval when PREVNAR 13 should be given? The caller was informed that we have ACIP guidelines for the interval to give PNEUMOVAX 23 but we don't have guidelines following receipt of two doses of PNEUMOVAX 23. The caller was informed that we would forward this inquiry to our product team as an urgent request and that they would follow up by phone." Additional information has been requested.
No additional AE reported; Customer called for a temperature excursion of VARIVAX was administered; This spontaneous report was received from a medical assistant referring to a unknown number of patients of unknown age and gender. The patients' medical history, historical drugs, concurrent conditions and concomitant medications were not provided.      On an unknown date, the patients were vaccinated with an improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot number W019628, expiration date 19-DEC-2023 (dose and route of administration) for prophylaxis (product storage error). No adverse event was reported.  No information about the temperature excursion was provided.  Follow up information has been received on 10-MAR-2023.  varicella virus vaccine live (Oka/Merck) (VARIVAX) (Lot numberW018828 expiration date 14-JUN-2024), and  Lot number W006412 expiration date 23-FEB-2024) (dose and route of administration) for prophylaxis (product storage error), and measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA)(PROQUAD) lot number W019627, expiration date 19-DEC-2023)  (product storage error).  Follow up information has been received on 18-APR-2023.  It referred to a 11 months old female patient. On 20-JAN-2023, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # W006412, expiration date 23-FEB-2024, intramuscular in the right thigh) for prophylaxis (product storage error). Temperature excursion occurred as result of reading from digital data logger.  This is one of several reports received from the same reporter.; Sender's Comments:  US-009507513-2303USA002114:
Urticaria, swelling, erythema same day as vaccination (local), hives spread and vomiting, fever, pneumonia, vasculitis all developed within 2 weeks post-vaccination.
pt. signed up online for Flu & Covid booster shots. at time of payment, cashier specifically asked for Flu payment and he and his wife ok'd and paid the copay.  In the immunization room, the intern asked him what vaccines he was here for and showed him 2 syringes, Covid and FLu.  He even asked the pharmacy intern what kind of flu shot he is getting.  He got his shots with no questions and when it was time for the wife, she questioned as to why I am getting 2 shots and was discovered he already got his hi dose flu on 10/27/22 at MD's office.
Severe angina.  has not had an episode of angina in a very long time.  This was the first time she had to use Nitro in years.  She took one dose, and three chewable 81 mg aspirin, and the symptoms subsided.  Blood pressure peaked 158/80 with a pulse of 69.  When the symptons subsided, no further action was taken.
About 12 hours after vaccination, I started feeling very lethargic and sore. I soon started feeling very cold and had uncontrollable shivers. My temp was 100.5 F at highest. I had trouble sleeping due to chills but my fever was gone by the morning. I  still feel very sore and tired.
This case was reported by a pharmacist via call center representative and described the occurrence of shoulder pain in a 72-year-old male patient who received SHINGRIX for prophylaxis. On 8th November 2018, the patient received the 1st dose of SHINGRIX (intramuscular) .5 ml. In November 2018, less than a week after receiving SHINGRIX, the patient experienced shoulder pain. The patient was treated with ibuprofen. On an unknown date, the outcome of the shoulder pain was not recovered/not resolved. It was unknown if the reporter considered the shoulder pain to be related to SHINGRIX. Additional details were provided as follows: The patient received SHINGRIX on an unknown arm. The patient came back to the pharmacy and complained of soreness in his shoulder and could not sleep on it. The reporter stated that, the sore shoulder was on the same arm in which he received the SHINGRIX, however, the reporter was not sure which arm. The reporter stated that, the patient took Ibuprofen for the pain. The reporter did not had lot number at the time of the reporting.
5/30 71y.o. female who presents for headaches, myalgias, fevers, dry heaves, nausea, loose stools. She reports that her husband was diagnosed with covid-19. He has been ill but not sick enough to go to the hospital.
This spontaneous report as received from a 74 years old male patient with no drug reactions/allergies and history of polio and parathyroid problems, who on 09-MAY-2012 was vaccinated with a dose of ZOSTAVAX 0.65 ml, subcutaneously (lot number not reported). No other co-suspects were reported. Concomitant medications included TRICOR, niacin and MIRAPEX. On 16-JUN-2012 the patient experienced another bout of shingles. He had had 2 very bad bouts of shingles before getting the vaccine. This time, he experienced a little rash between his elbow and shoulder in his upper right arm. It hurt to touch his skin there, like the area had been burnt. NO treatment was given for the events. The patient stated that this pain was diminishing and the rash was going away. No laboratory diagnostic studies were performed. The patient did not seek medical attention. Additional information has been requested.
Patient came to ED with chest pain.  Patient admitted to hospital with Covid pneumonia and treated with remdesivir.
pt recvd vax 27OCT95 & 7NOV95 pt devel a chicken pox like rash;in f/u the nurse reported that it was determined that the rash was related to therapy w/phenobarb & not to varicella vax
Full body rash starting at the sight of injection. Itchy, red and hot. Changed the difference of skin tone
FLU-LIKE SYMPTOMS; BODY ACHES; CHILLS; FATIGUE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805029, and expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination on left arm. No concomitant medications were reported. On 21-MAR-2021, the subject experienced flu-like symptoms. On 21-MAR-2021, the subject experienced body aches. On 21-MAR-2021, the subject experienced chills. On 21-MAR-2021, the subject experienced fatigue. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from body aches, and had not recovered from flu-like symptoms, chills, and fatigue. This case is associated with PQC number 90000174263. This report was non-serious.
Patient developed lip swelling post vaccination.  Benadryl given on scene.  Symptoms rapidly resolved.  Did not go to hospital at the time.  Next day called a telemedicine service for recurrence of symptoms, called and urgent care too.  Advised to go to ER.  Went to ER and received IV bendaryl.  Discharged to home.
she was dying as her blood pressure dropped to 70/40 and to come for a last visit; This is a spontaneous report from a contactable consumer. A 100-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 02Jan2021 at single dose for COVID-19 immunization.  Medical history included COVID in Dec2020, urinary tract infection (UTI), dehydration and Covid sickness (vomiting) (was treated earlier in month for UTI and dehydration from the Covid sickness (vomiting)). Known allergies: no. The patient's concomitant medications were not reported. After testing positive in mid December to COVID and being declared Covid free on 30Dec by the nursing staff and in good health, with normal vitals and oxygen levels, the patient was given a vaccination on 02Jan2021. In the early evening the patient's blood pressure dropped to 70/40 and the reporter was told to come for a last visit. The patient was sleeping comfortably. She did not wake up when spoke with her. No one expected her to make it through the night. The next morning she work up, ate breakfast, watched TV, got IVs and oxygen and her vitals improved significantly. Lab tests and procedures included blood pressure: 70/40 on 02Jan2021, oxygen levels: normal, COVID test: positive in Dec2020 (testing positive in mid December to COVID and being declare Covid free on 30Dec), vitals: normal; improved significantly. Facility where the most recent COVID-19 vaccine was administered: Nursing Home/Senior Living Facility. If the patient received any other vaccines within 4 weeks prior to the COVID vaccine: No. Prior to vaccination, was the patient diagnosed with COVID-19: Yes. Since the vaccination, has the patient been tested for COVID-19: No. AE resulted in: Life threatening illness (immediate risk of death from the event). Serious: Yes. Seriousness criteria-Results in death: No. Seriousness criteria-Life threatening: Yes. Seriousness criteria-Caused/prolonged hospitalization: No. Seriousness criteria-Disabling/Incapacitating: No. Seriousness criteria-Congenital anomaly/birth defect: No.  Information about lot/batch number has been requested.
Approximately 36-48 hrs after vaccination, pt developed swelling and redness and tenderness of the left arm. Upon exam pt was found to have swelling and erythema of approx. 60-75% of his arm from the elbow up. Additionally his elbow was also swollen and had decreased ROM.
This spontaneous report was received from a nurse and refers to a 5 month old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 12-SEP-2017, the patient was vaccinated with improperly stored RECOMBIVAX HB (dosing details not reported) (lot # N006321, expiry date: 08-NOV-2019) for prophylaxis. No adverse effects were reported. The administered vaccine underwent a temperature excursion from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1709USA007011.
Local reaction (swelling, erythema, induration and tenderness) to either pneumococcal or Dtap vaccine. Walking but dragging (L) leg.
Best describes as "brain fog" starting 48 hours after booster. Plus I was easily agitated and clumsy. The symptoms lasted approximately 10 days.
5 weeks after I received the vaccine, I was dizzy. Spinning when I moved too much , nausea and woozy head.  I improved but after 3 weeks, symptoms came back.  For 5 days I have had woozyness been unsteady  and when walking.  I Have had vertigo in the past, but never for one month.  This feels  different.
No adverse event; 47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date) and NO ADVERSE EVENT (No adverse event) in an adult patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. AS7642B) for COVID-19 prophylaxis.     No Medical History information was reported.  On 22-Jun-2023, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 22-Jun-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (47 patients received the Moderna Covid-19 bivalent vaccine after the use-by date).    Concomitant product use was not provided by the reporter.  Staff gave patients vaccines past the use date of 18-Jun-2023.  On 22-Jun-2023, 5 doses were administered at administration site 2.   Treatment information was not provided.  This case contains information for the 24th patient out of 47 adult patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-732752 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2023: Live Follow-up received suspect vaccine details added, iNarrative updated.; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-732752:Master Case (Patient 1)
Vesicular rash of the arm 1 week after vaccine followed by large blister on sole of foot and  vesicular rash spreading to the neck over the course of 2 months
Experienced pain in my left arm at the injection site along with feeling an increase level of tiredness.
I received the vaccine at 4:00PM. I got a welt after getting the shot at about 9pm. I also got a rash that spread from my chest to breast area. I had no change in medicine. At midnight I had a fever of 104 degrees, and no medications brought it down. I had a headache and felt extreme exhaustion. I was throwing up 3 days after. I went to the doctor to check to see if I had food poisoning but that was negative.
Rash on forearms and itching (10 minutes after, lasted for an hour and a half). Headache (started half an hour after vaccine; comes and goes. Continuous since waking up 3 hours ago). Chills (started five hours after vaccine; still experiencing the next day). Nausea. Sore throat. Sore arm. Fatigue.
Starting the evening of Friday, 9/28, I experienced severe body aches, headache, chills, fever of 100.6 taken under the arm w/digital thermometer, lack of appetite, weakness, shakiness, heavy sweating.  The worst was all day Saturday, then midway through Sunday I noticed a lessening of the body aches and the increase of an extreme headache which lasted through Monday and slightly less on Tuesday. The level of severity of the symptoms was such that I had to be in bed from Friday night through Tuesday morning.  This is unusual for me, as I rarely am sick enough to stay in bed and/or miss work.
Headache, Myalgia, NauseaVomiting, Fatigue, Chills. Narrative:
has administered MENACTRA to a pregnant patient, with no reported adverse event; Initial information from received on 24-Jun-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an 18 years old female patient who was exposed to vaccine Meningococcal A-C-Y-W135 (D conj) vaccine [Menactra] during her pregnancy, with no reported adverse event.  Data regarding this pregnancy were received prospectively, i.e. before pregnancy outcome was known. The reported administration of Meningococcal A-C-Y-W135 (D conj) vaccine during pregnancy occurred at unknown gestation period.  The date of last menstrual period was not reported. The estimated due date was not reported. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had unknown previous pregnancy/ies.   On an unknown date, the patient received 0.5 mL dose of suspect meningococcal A-C-Y-W135 (D CONJ) vaccine (lot: U7273BA, expiry date: 24-apr-2023; formulation not reported) via intramuscular route in the right deltoid for prophylactic immunization.  On an unknown date, the meningococcal A-C-Y-W135 (D CONJ) vaccine was administered to a pregnant patient, with no reported adverse event (exposure during pregnancy).  Action taken was not applicable.  Outcome: Unknown   Additionally, at time of reporting, the outcome of the pregnancy is unknown.
Patient received 1st dose pfizer at mass vax event.  Scheduled and came to clinic on 3/30/2021 and received MODERNA.  No adverse reactions reported at time of vaccine, none reported after administration.
The pt experienced 8 x 10 cm area of erythema with heat to right thigh. No induration, no tenderness. Pt has full range of motion to leg. No adenopathy, walks well.
Symptoms started with numbness/tingling in buttocks, constipation, urinary incontinence, followed by ascending paralysis to waist over a 2 1/2 day period.  Sought treatment on 1/13/2012 in ER, and admitted on 1/14/2012 for diagnosis of Guillain-Barre, treated with IVIG.  Hospitalized for four days, and retreated with another course of IVIG on Feb 6 and 7, 2012.  Currently, have partial recovery of legs/bladder/bowel.  Have been going to physical therapy 3/weekly, and have not yet returned to my pediatric practice.  Still have partial paralysis and fatigue. Permanent residual status unknown at this time.
I just had a tetanus shot and you did not have the word "tetanus" to choose from. The Practitioner put the shot into my left shoulder bursa  and NOT in my deltoid. My orthopedic doctor said I got adhesive capsulitis from the nurse shooting tetanus into my shoulder joint and am developing a frozen shoulder. My shoulder was fine and never had a problem with it before this happened.
Pt had cough on am of 10-16-09 and went to ER @ 5:00 on 10-17-09 presenting with cough, sob, temp 102.9 F post tussive vomiting, dg: acute bronchitis. Rx AMOXICILLIN, ALBUTEROL (per neb) and tamiflu. Pt well after 5 days.
Extreme pain at injection site - within 6 hours, continuing over 24 hours  Fever - 100.9 steady beginning 1300 2/6/21 and dropping to 99.8 and steady over 4+ hours, continuing  Abdominal Pain - within 6 hours, continuing over 24 hours  Nausea - mild, began within 3 hours, lasting on and off over 24 hours  Extreme muscle and joint pain - began within 6 hours, continuing over 24 hours  Sleepiness/Fatigue - began within 6 hours, lasting over 24 hours Tension headache  - extreme, excedrin takes care of it
This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender. On 17-AUG-2013 the patient was vaccinated with an expired dose of vaccine: M-M-R II (lot # 670618/0567AA, exp. date 15-APR-2013), 0.5 milliliters (ml) injection, subcutaneously. No adverse effect was reported. This is one of several reports from the same source. Additional information has been requested.
Fever to 102.5°. No rash, no site swelling, shoulder hurts. Had headache, malaise, now better.